Galzi JL - Search Results

1

Topological analysis of the complex formed between neurokinin A and the NK2 tachykinin receptor.

Zoffmann S, Bertrand S, Do QT, Bertrand D, Rognan D, Hibert M, Galzi JL. Zoffmann S, et al. Among authors: galzi jl. J Neurochem. 2007 Apr;101(2):506-16. doi: 10.1111/j.1471-4159.2007.04473.x. J Neurochem. 2007. PMID: 17402972 Free article.

2

Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding properties.

Ilien B, Franchet C, Bernard P, Morisset S, Weill CO, Bourguignon JJ, Hibert M, Galzi JL. Ilien B, et al. Among authors: galzi jl. J Neurochem. 2003 May;85(3):768-78. doi: 10.1046/j.1471-4159.2003.01717.x. J Neurochem. 2003. PMID: 12694403 Free article.

3

A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties.

Maillet EL, Pellegrini N, Valant C, Bucher B, Hibert M, Bourguignon JJ, Galzi JL. Maillet EL, et al. Among authors: galzi jl. FASEB J. 2007 Jul;21(9):2124-34. doi: 10.1096/fj.06-7683com. Epub 2007 Mar 19. FASEB J. 2007. PMID: 17371796

4

Allosteric functional switch of neurokinin A-mediated signaling at the neurokinin NK2 receptor: structural exploration.

Valant C, Maillet E, Bourguignon JJ, Bucher B, Utard V, Galzi JL, Hibert M. Valant C, et al. Among authors: galzi jl. J Med Chem. 2009 Oct 8;52(19):5999-6011. doi: 10.1021/jm900671k. J Med Chem. 2009. PMID: 19746979

5

Identification of the extracellular loop 2 as the point of interaction between the N terminus of the chemokine MIP-1alpha and its CCR1 receptor.

Zoffmann S, Chollet A, Galzi JL. Zoffmann S, et al. Among authors: galzi jl. Mol Pharmacol. 2002 Sep;62(3):729-36. doi: 10.1124/mol.62.3.729. Mol Pharmacol. 2002. PMID: 12181451

6

The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states.

Palanche T, Ilien B, Zoffmann S, Reck MP, Bucher B, Edelstein SJ, Galzi JL. Palanche T, et al. Among authors: galzi jl. J Biol Chem. 2001 Sep 14;276(37):34853-61. doi: 10.1074/jbc.M104363200. Epub 2001 Jul 17. J Biol Chem. 2001. PMID: 11459843 Free article.

7

Fluorescent pirenzepine derivatives as potential bitopic ligands of the human M1 muscarinic receptor.

Tahtaoui C, Parrot I, Klotz P, Guillier F, Galzi JL, Hibert M, Ilien B. Tahtaoui C, et al. Among authors: galzi jl. J Med Chem. 2004 Aug 12;47(17):4300-15. doi: 10.1021/jm040800a. J Med Chem. 2004. PMID: 15294002

8

Fluorescent derivatives of AC-42 to probe bitopic orthosteric/allosteric binding mechanisms on muscarinic M1 receptors.

Daval SB, Valant C, Bonnet D, Kellenberger E, Hibert M, Galzi JL, Ilien B. Daval SB, et al. Among authors: galzi jl. J Med Chem. 2012 Mar 8;55(5):2125-43. doi: 10.1021/jm201348t. Epub 2012 Feb 27. J Med Chem. 2012. PMID: 22329602

9

On the use of nonfluorescent dye labeled ligands in FRET-based receptor binding studies.

Tahtaoui C, Guillier F, Klotz P, Galzi JL, Hibert M, Ilien B. Tahtaoui C, et al. Among authors: galzi jl. J Med Chem. 2005 Dec 1;48(24):7847-59. doi: 10.1021/jm050459+. J Med Chem. 2005. PMID: 16302823

10

Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway Hypereosinophilia.

Regenass P, Abboud D, Daubeuf F, Lehalle C, Gizzi P, Riché S, Hachet-Haas M, Rohmer F, Gasparik V, Boeglin D, Haiech J, Knehans T, Rognan D, Heissler D, Marsol C, Villa P, Galzi JL, Hibert M, Frossard N, Bonnet D. Regenass P, et al. Among authors: galzi jl. J Med Chem. 2018 Sep 13;61(17):7671-7686. doi: 10.1021/acs.jmedchem.8b00657. Epub 2018 Aug 28. J Med Chem. 2018. PMID: 30106292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters